FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 345:1853-1855 December 20, 2001 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: For a study that was conducted at 22 centers in the United States and that involved patients with a disease that has a worldwide prevalence of 2 percent, the recruitment of only 229 patients with psoriasis, as reported by Ellis and Krueger (July 26 issue),¹ raises the question of why so few patients were selected to participate.

Furthermore, the sponsor of the study (Biogen) "collected the data and performed the statistical analysis." Did the authors have access to any raw data, and was the analysis verified by an independent statistician before publication of the report? In addition, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.